Company filings profile · CIK 0001894525
Apimeds Pharmaceuticals US, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Apimeds Pharmaceuticals US, Inc. (APUS): 6 filings in the last 90 days vs 12 in the prior 90 (filing-velocity cooling ↓ · 0.5×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Sep 23, 2026. Source-linked, daily-refreshed.
Material 8-K events — Apimeds Pharmaceuticals US, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Sep 23, 2026 | Item 3.03; Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Sep 11, 2026 | Entry into a Material Agreement; Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Aug 21, 2026 | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Aug 6, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Jul 13, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| May 5, 2026 | Departure/Election of Directors or Officers | ↗ |
| May 4, 2026 | Entry into a Material Agreement; Departure/Election of Directors or Officers; Other Events; Financial Statements and Exhibits | ↗ |
| Apr 22, 2026 | Delisting / Listing-Rule Failure; Financial Statements and Exhibits | ↗ |
| Apr 16, 2026 | Other Events | ↗ |
| Mar 26, 2026 | Departure/Election of Directors or Officers; Amendments to Bylaws/Charter; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 25, 2026 | Departure/Election of Directors or Officers; Amendments to Bylaws/Charter; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 16, 2026 | Other Events | ↗ |
| Jan 2, 2026 | Departure/Election of Directors or Officers | ↗ |
| Dec 10, 2025 | Departure/Election of Directors or Officers | ↗ |
| Dec 2, 2025 | Entry into a Material Agreement; Completion of Acquisition/Disposition; Material Direct Financial Obligation; Unregistered Sale of Securities; Change in Control; Departure/Election of Directors or Officers; Amendments to Bylaws/Charter; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
Watch Apimeds Pharmaceuticals US, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Sep 23, 2026 | 8-K | Item 3.03; Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Sep 11, 2026 | 8-K | Entry into a Material Agreement; Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Aug 21, 2026 | 8-K | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Aug 14, 2026 | 10-Q | QUARTERLY REPORT | ↗ |
| Aug 6, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Jul 13, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| May 26, 2026 | 10-Q | QUARTERLY REPORT | ↗ |
| May 15, 2026 | NT 10-Q | NOTIFICATION OF LATE FILING | ↗ |
| May 7, 2026 | SCHEDULE 13D/A | ↗ | |
| May 5, 2026 | 8-K | Departure/Election of Directors or Officers | ↗ |
| May 4, 2026 | 10-K | ANNUAL REPORT | ↗ |
| May 4, 2026 | 8-K | Entry into a Material Agreement; Departure/Election of Directors or Officers; Other Events; Financial Statements and Exhibits | ↗ |
| Apr 22, 2026 | 8-K | Delisting / Listing-Rule Failure; Financial Statements and Exhibits | ↗ |
| Apr 16, 2026 | 8-K | Other Events | ↗ |
| Apr 9, 2026 | 425 | AMENDMENT NO. 1 TO FORM 8-K | ↗ |
| Apr 9, 2026 | 8-K/A | Departure/Election of Directors or Officers; Amendments to Bylaws/Charter; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 31, 2026 | NT 10-K | NOTIFICATION OF LATE FILING | ↗ |
| Mar 30, 2026 | SCHEDULE 13D/A | ↗ | |
| Mar 26, 2026 | 8-K | Departure/Election of Directors or Officers; Amendments to Bylaws/Charter; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 25, 2026 | 8-K | Departure/Election of Directors or Officers; Amendments to Bylaws/Charter; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 20, 2026 | SCHEDULE 13D/A | ↗ | |
| Mar 16, 2026 | 8-K | Other Events | ↗ |
| Feb 27, 2026 | DEFM14C | INFORMATION STATEMENT | ↗ |
| Feb 17, 2026 | 425 | AMENDMENT NO. 2 TO FORM 8-K | ↗ |
| Feb 17, 2026 | 8-K/A | Completion of Acquisition/Disposition; Financial Statements and Exhibits | ↗ |
| Feb 11, 2026 | SCHEDULE 13G | ↗ | |
| Jan 26, 2026 | SCHEDULE 13D/A | ↗ | |
| Jan 16, 2026 | PREM14C | INFORMATION STATEMENT | ↗ |
| Jan 2, 2026 | 8-K | Departure/Election of Directors or Officers | ↗ |
| Dec 10, 2025 | 8-K | Departure/Election of Directors or Officers | ↗ |
| Dec 10, 2025 | 8-K/A | Entry into a Material Agreement; Item 3.03; Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Dec 2, 2025 | 425 | CURRENT REPORT | ↗ |
| Dec 2, 2025 | 8-K | Entry into a Material Agreement; Completion of Acquisition/Disposition; Material Direct Financial Obligation; Unregistered Sale of Securities; Change in Control; Departure/Election of Directors or Officers; Amendments to Bylaws/Charter; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Nov 21, 2025 | 4/A | PRIMARY DOCUMENT | ↗ |
| Nov 18, 2025 | 8-K | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Nov 13, 2025 | 4 | PRIMARY DOCUMENT | ↗ |
| Nov 13, 2025 | 4 | PRIMARY DOCUMENT | ↗ |
| Nov 13, 2025 | 4 | PRIMARY DOCUMENT | ↗ |
| Nov 13, 2025 | 4 | PRIMARY DOCUMENT | ↗ |
| Nov 13, 2025 | 4 | PRIMARY DOCUMENT | ↗ |